CA2450022A1 — Method of testing drug for treating or preventing diseases such as hyperlipemia
Assigned to Individual · Expires 2002-12-19 · 23y expired
What this patent protects
It is intended to provide a novel method of testing a remedy or a preventive for at least one disease selected from among hyperlipemia, arteriosclerosis and hyperglycemia. More specifically, a method which comprises culturing cultured cells in the presence or absence of a test su…
USPTO Abstract
It is intended to provide a novel method of testing a remedy or a preventive for at least one disease selected from among hyperlipemia, arteriosclerosis and hyperglycemia. More specifically, a method which comprises culturing cultured cells in the presence or absence of a test substance, detecting the mRNA expression dose, promoter activity or protein production level of ~angiopoetin-associated protein 3 or 4~ gene, and thus selecting a test substance showing a lowered mRNA expression dose, promoter activity or protein production level thus detected in the cells cultured in the presence thereof compared with the cells cultured in the absence thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.